KRAS (but not BRAF) mutations in ovarian serous borderline tumor are associated with recurrent low-grade serous carcinoma

BRAF and KRAS mutations in ovarian serous borderline tumors (OSBTs) and ovarian low-grade serous carcinomas (LGSCs) have been previously described. However, whether those OSBTs would progress to LGSCs or those LGSCs were developed from OSBT precursors in previous studies is unknown. Therefore, we as...

Full description

Saved in:
Bibliographic Details
Main Authors: Tsang, Yvonne T., Deavers, Michael T., Sun, Charlotte C., Kwan, Suet-Yan, Kuo, Eric, Malpica, Anais, Mok, Samuel C., Gershenson, David M., Wong, Kwong-Kwok
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4095747/
https://ncbi.nlm.nih.gov/pubmed/24549645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.4252
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items